image
Aclaris Therapeutics, Inc. ACRS
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
Watchlist
$ 2.05
-5.96 %
$ 146 M
Market Cap
-4.36
P/E
INCOME STATEMENT
31.2 M REVENUE
5.03%
Growth Rates
1Year 5.03%
3Years 68.93%
5Years 25.37%
7Years 0.00%
10Years 0.00%
-97.4 M OPERATING INCOME
-14.33%
Growth Rates
1Year -14.33%
3Years -24.12%
5Years 6.39%
7Years -10.45%
10Years -33.89%
-88.5 M NET INCOME
-1.81%
Growth Rates
1Year -1.81%
3Years -20.15%
5Years 7.79%
7Years -9.10%
10Years -32.67%
EFFICIENCY
Earnings Waterfall Aclaris Therapeutics, Inc.
image
Revenue 31.2 M
Cost Of Revenue 18.1 M
Gross Profit 13.2 M
Operating Expenses 111 M
Operating Income -97.4 M
Other Expenses -8.88 M
Net Income -88.5 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 31.2 29.8 6.8 6.5 4.2 10.1 1.7 0 0 0 0
GROSS PROFIT
Cost Of Revenue 18.1 12.0 4.7 5.1 4.1 6.8 1.2 0.1 90 K 0 0
Gross Profit 13.2 17.8 2.0 1.3 0.2 3.2 0.5 (0.1) 90 K 0 0
OPERATING INCOME
Operating Expenses 110.5 102.9 67.4 52.3 92.7 138.7 72.9 48.6 20.7 8.5 5.3
Selling, General and Administrative Expenses 31.1 25.1 23.6 20.5 27.8 75.6 33.1 15.1 5.3 2.0 1.8
Research and Development Expenses 98.4 77.8 43.8 31.7 64.9 63.0 39.8 33.5 15.3 6.5 3.5
Operating Income (97.4) (85.2) (65.4) (50.9) (111.1) (135.4) (72.4) (48.6) (20.7) (8.5) (5.3)
PRE-TAX INCOME
Interest Income Expense 0 4.7 0 0 0 0 0 0 0 0 0
Total Other Income 8.5 2.9 (1.1) (0.4) (2.5) 2.7 (16.0) 0.5 0.1 16 K 21 K
Pre-Tax Income (88.8) (86.9) (90.9) (51.3) (113.5) (132.7) (70.4) (48.1) (20.6) (8.5) (5.2)
NET INCOME
Tax Provision (0.4) 1.8 23.4 (0.2) 29.3 2.7 (1.8) (0.1) 90 K 0 0
Net Income (88.5) (88.7) (114.3) (51.2) (142.8) (132.7) (68.5) (48.1) (20.6) (8.5) (5.2)
EPS 1.27 1.36 2.01 1.2 3.46 4.03 2.44 2.25 3.37 0.8 0.49